AIDS News and Research

RSS

Viral Genetics announces effects of VGV-1 in antiretroviral non-responding HIV infections

Viral Genetics announced today that the results of a clinical trial of its investigational therapy for HIV infection, VGV-1, were recently published in a peer reviewed journal, HIV & AIDS Review.

29 Nov 2004

Older Australians face a tough time in court

New research has revealed that many older Australians find themselves at a distinct disadvantage when fronting court because of hearing impairment, physical immobility and difficulty coping with complex procedures.

29 Nov 2004

Lighter air more than doubles COPD patients’ endurance

It certainly makes sense: COPD sufferers have varying degrees of serious breathing difficulties, which keeps them from almost any kind of exercise, especially in advanced stages. So maybe “lighter than air” air would be easier to breath, reduce shortness of breath and perhaps even allow them to do some exercise with all of its physical and mental benefits.

29 Nov 2004

One in five women with HIV in the United States has no health insurance

One in five women with HIV in the United States has no health insurance. Half of the estimated 460,000 women and men who need lifesaving antiretroviral drugs are not getting them, according to a recent report by the Institute of Medicine (IOM) of the National Academy of Sciences.

29 Nov 2004

Guatemalan Congress repeals law that restricted access to medicines

The Guatemalan Congress's repeal of a law that severely restricts people's access to affordable essential medicines is a positive step forward.

29 Nov 2004

53,000 adults living with HIV/AIDS in the UK

There are now 53,000 adults living with HIV/AIDS in the UK, over a quarter of whom (14,300) remain unaware of their infection according to the Health Protection Agency's annual report on HIV.

29 Nov 2004

Rigour and Vigour Conference: Directions in HIV Prevention

Curtin University of Technology, Australia, will host the Rigour and Vigour Conference: Directions in HIV Prevention tomorrow to coincide with World AIDS Day on Wednesday 1 December.

29 Nov 2004

Moldova making progress in fight against HIV/AIDS and tuberculosis

Moldova’s early actions to fight HIV/AIDS and tuberculosis are slowing the rise of the country’s dual tuberculosis and AIDS epidemics, the World Bank reports.

29 Nov 2004

4 million extra health workers needed worldwide

Authors of a public-health article in this week’s issue of THE LANCET are calling for urgent international action to address the chronic lack of investment in human resources which is limiting the chance of tackling diseases such as HIV/AIDS, malaria, and TB.

29 Nov 2004

New computer-aided diagnosis (CAD) methods for cancer

Not all masses are cancer. When a person undergoes a scan to identify a lump or nodule, the radiologist looks at the texture, the borders and the shape to determine if it is malignant or just a benign growth.

29 Nov 2004

Female condoms should be promoted as an effective solution to prevent the spread of HIV/AIDS

While scientists work to find the 'perfect' solution to preventing the spread of HIV/AIDS, a reasonable option--the female condom--is not being promoted, especially in African and southeast Asian countries where the deadly virus is most prevalent, according to a new study.

24 Nov 2004

Women now making up nearly half of the 37.2 million adults (aged 15-49) living with HIV worldwide

A new report released today shows that the number of women living with HIV has risen in each region of the world over the past two years, with the steepest increases in East Asia, followed by Eastern Europe and Central Asia. In East Asia, there was a 56% increase over the past two years, followed by Eastern Europe and Central Asia with 48%.

23 Nov 2004

Long-term use of opioid prescriptions by veterans

Veteran patients who receive long-term opioid prescriptions generally are treated with modest and stable medication dosages, according to an article in the November 22 issue of The Archives of Internal Medicine, one of the JAMA/Archives journals.

23 Nov 2004

Pyramid sampling method to be used to track HIV-risk behavior among drug users in 25 cities

What's the best way to get a statistically reliable sample of people who are hard to identify, such as illegal-drug users in large cities, itinerant jazz musicians, aging Manhattan artists and semi-professional storytellers?

20 Nov 2004

$10.4 million to provide support for HIV/AIDS research in Peru, Thailand, Cambodia and Russia

HHS Secretary Tommy G. Thompson has announced four new grants totaling $10.4 million to provide support for HIV/AIDS research in Peru, Thailand, Cambodia and Russia, four nations that have been hard hit by the AIDS epidemic.

19 Nov 2004

FDA Vioxx fiasco raises questions about AIDS drug approvals for developing world

AIDS Healthcare Foundation (AHF), today noted that the current "FDA fiasco" involving the agency's initial approval and subsequent recall of Merck's troubled arthritis drug, Vioxx, raises serious questions about the FDA's ongoing parallel role in the approval of generic AIDS drugs for widespread use in Africa and the developing world.

19 Nov 2004

Animal research and its benefits to both humans and animals

From preventing polio to finding cures for cancer patients, animal research has saved countless lives.

18 Nov 2004

Biotoxin from puffer fish may provide treatment for opioid withdrawal

On November 10, 2004 investigators involved in a Phase IIa clinical trial of the novel biotoxin Tetrodotoxin (TTX) for the treatment of opioid withdrawal enrolled their first participants.

18 Nov 2004

Generic antipsychotic drugs can protect brain cells from progressive multifocal leukoencephalopathy

Generic antipsychotic drugs can protect brain cells from a virus that causes a fatal nervous system disorder, according to research conducted at Brown University and Case Western Reserve University.

18 Nov 2004

Silicone facial implants provide HAART patients with a healthier appearance

Highly active antiretroviral therapy (HAART) for the treatment of HIV/AIDS is the name given to treatment regimens recommended by leading HIV experts to aggressively suppress viral replication and progress of HIV disease. These treatment regimens have been shown to reduce the amount of virus so that it becomes undetectable in a patient's blood.

16 Nov 2004